Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.97 USD | +1.04% | +1.03% | -9.35% |
Business Summary
Number of employees: 31
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Buell
CEO | Chief Executive Officer | 50 | 21-01-31 |
Heather Boussios
CMP | Compliance Officer | - | - |
Marc van Dijk
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-02-29 |
Zack Armen
IRC | Investor Relations Contact | - | - |
Treasurer | 58 | 17-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CHM | Chairman | 71 | 17-06-30 |
Director/Board Member | 66 | 17-06-30 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 21-08-31 |
Brian Corvese
BRD | Director/Board Member | 67 | 17-06-30 |
Peter Behner
BRD | Director/Board Member | 61 | 21-03-31 |
Jennifer Buell
CEO | Chief Executive Officer | 50 | 21-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 39,367,639 | 9,991,083 ( 25.38 %) | 0 | 25.38 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.35% | 38.16M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- INKT Stock
- Company MiNK Therapeutics, Inc.